U.S. FDA Drug Shortages Tracker & Medication Availability Index

Inclusion on this index reflects official U.S. FDA shortage listings or regional market supply bottlenecks. This tracker serves as an educational resource and does not substitute professional medical advice.

International prescription verification and fulfillment remain subject to valid physician authorization and personal importation guidelines. Always consult your primary healthcare provider before modifying or switching any prescribed treatment.

FDA Status: DiscontinuedVibramycin
Vibramycin
Brand

U.S. domestic supply disruptions and discontinuations affect Doxycycline Hyclate delayed-release (DR) formulations. Review the FDA status report and explore compliant international sourcing for authentic brand-name Vibramycin and Periostat oral formulations.

Read more
FDA Status: DiscontinuedAricept
Aricept
Brand

U.S. domestic supply chain disruptions and product discontinuations affect fixed-dose Namzaric combination capsules. Review the FDA status report and explore compliant international sourcing for separate Aricept (Donepezil) and Namenda (Memantine) oral tablets.

Read more
FDA Status: In ShortageTrexall
Trexall
Brand

US domestic supply chain disruptions continue to affect Methotrexate Sodium, specifically targeting hospital-grade injectable formulations. Review the FDA shortage status, critical safety information, and independent access options for oral Trexall tablets.

Read more
FDA Status: In ShortageMedrol
Medrol
Brand

US domestic supply chain disruptions continue to affect Methylprednisolone Acetate, specifically targeting hospital and clinical injectable suspensions. Review the FDA shortage status, safety information, and independent access options for oral Medrol pills.

Read more
FDA Status: In ShortageLasix
Lasix
Brand

US domestic supply chain disruptions continue to impact Furosemide, targeting liquid formulations such as IV injections and oral solutions. Read the FDA status report and explore international availability for oral Lasix tablets.

Read more
FDA Status: In ShortageFlagyl
Flagyl
Brand

US domestic supply chain disruptions continue to affect Metronidazole, specifically targeting hospital-grade injectable solutions. Review the FDA shortage status, critical safety information, and independent access options for oral Flagyl pills.

Read more
FDA Status: In ShortageCleocin
Cleocin
Brand

US domestic supply disruptions continue to affect Clindamycin Phosphate, primarily targeting hospital-grade injectable solutions. Learn about the shortage status and access options for oral Cleocin capsules.

Read more
FDA Status: In ShortageInderal
Inderal
Brand

US domestic supply chain disruptions continue to affect Propranolol Hydrochloride, specifically targeting hospital-grade injectable solutions. Review the FDA shortage status, safety alerts, and independent access options for oral Inderal tablets.

Read more
FDA Status: In ShortageDepakote
Depakote
Brand

US domestic supply chain disruptions continue to affect Valproate Sodium, specifically targeting hospital-grade intravenous solutions. Review the FDA shortage status, critical safety information, and independent access options for oral Depakote tablets.

Read more
FDA Status: In ShortageBumex
Bumex
Brand

FDA shortage monitoring for Bumetanide Injection. Learn about sourcing options for Bumex oral tablets from accredited UK/EU partner pharmacies under personal importation guidelines.

Read more
FDA Status: In ShortageVentolin
Ventolin
Brand

FDA shortage monitoring for Albuterol Sulfate Inhalation Solution. Learn about sourcing options for Ventolin meter-dose inhalers from accredited UK/EU partner pharmacies under personal importation guidelines.

Read more
FDA Status: In ShortageAccuretic
Accuretic
Brand

FDA shortage monitoring for Accuretic (Quinapril / Hydrochlorothiazide) oral tablets. Learn about sourcing options from accredited UK/EU partner pharmacies under personal importation guidelines.

Read more

🍪 We use cookies

We use cookies to enhance your browsing experience, serve personalised content, and analyse traffic. By clicking "Accept all", you consent to our use of cookies.